Manmeet Singh Soni's Trading History
| SMMTSummit Therapeutics | Jun 04, 2026 | COO & CFO, Director | Informative Buy | 722.25K | $50.07M | |
| RETAReata Pharmaceuticals | Sep 26, 2023 | ― | Uninformative Sell | ― | $0.00 | |
| ARNAArena Pharma | Jun 18, 2020 | ― | Uninformative Sell | 19.07K | $590.14K | |
| ALNYAlnylam Pharma | Aug 14, 2018 | CFO | Uninformative Buy | ― | $13.70K | |
| ~ARIAAriad | Feb 16, 2017 | ― | Uninformative Sell | ― | ― | |
| PCYCPharmacyclics | May 27, 2015 | ― | Uninformative Sell | 14.11M | ― | |
| PLSEPulse Biosciences | ― | Director | ― | ― |
You May Also Like
Manmeet Singh Soni insider profile FAQ
What is the percentage of profitable transactions made by Manmeet Singh Soni?
The percentage of profitable transactions made by Manmeet Singh Soni is 100%.
What is the average return per transaction made by Manmeet Singh Soni?
The average return per transaction made by Manmeet Singh Soni is 207.90%.
What stocks does Manmeet Singh Soni hold?
Manmeet Singh Soni holds: PLSE, ALNY, ARNA, ~ARIA, PCYC, SMMT, RETA stocks.
What was Manmeet Singh Soni's most profitable transaction?
Manmeet Singh Soni’s most profitable transaction was an Informative Buy of SMMT stock on October 16, 2023. The return on the trade was 800.00%.
What is Manmeet Singh Soni's role in Pulse Biosciences?
Manmeet Singh Soni's role in Pulse Biosciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.